Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain

Journal of Pain and Symptom Management

Volumn 30, Issue 5, 2005, Pages 485-491

  Mercadante, Sebastiano ^a   Arcuri, Edoardo ^b   Ferrera, Patrizia ^a   Villari, Patrizia ^a   Mangione, Salvatore ^c  

^a LA MADDALENA CANCER CENTER   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Breakthrough pain; Cancer pain; Local anesthetics; Spinal analgesics

Indexed keywords

ANALGESIC AGENT; CLONIDINE; FENTANYL; KETAMINE; LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; METHADONE; MORPHINE; OPIATE;

ADVANCED CANCER; ADVERSE DRUG REACTION; AGITATION; ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DOSE RESPONSE; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; DYSPHORIA; DYSURIA; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; LEG; MALE; MUSCLE WEAKNESS; NEUROPATHIC PAIN; PAIN; SIDE EFFECT; SPINAL ANESTHESIA;

ADMINISTRATION, SUBLINGUAL; ADULT; AGED; ANALGESICS; ANESTHETICS, LOCAL; BUPIVACAINE; FEMALE; HUMANS; INJECTIONS, SPINAL; KETAMINE; MALE; MIDDLE AGED; NEOPLASMS; PAIN;

EID: 28344436049     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.04.014     Document Type: Article

References (18)

1. G.W. Hanks and Expert Working Group of the Research Network of the European Association for Palliative Care Morphine and alternative opioids in cancer pain: the EAPC recommendations Br J Cancer 84 2001 587 593
2. S. Mercadante, P. Villari, and P. Ferrera Dialogues on complex analgesic strategies for difficult pain syndromes Support Care Cancer 12 2004 599 603
3. S. Mercadante Problems of long-term spinal opioid treatment in advanced cancer patients Pain 79 1999 1 13
4. R.K. Portenoy, and N.A. Hagen Breakthrough pain: definition, prevalence, and characteristics Pain 41 1990 273 281
5. S. Mercadante and Steering Committee of the European Association for Palliative Care (EAPC) Research Network Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care Cancer 94 2002 832 839
6. P. Coluzzi, L. Schwartzberg, and J. Conroy Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulphate immediate release (MSIR) Pain 91 2001 123 130
7. J. Christie, M. Simmonds, and R. Patt Dose-titration multicenter study of transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain J Clin Oncol 16 1998 3238 3245
8. R.K. Portenoy, R. Payne, and P. Coluzzi Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study Pain 79 1999 303 312
9. S. Mercadante, P. Villari, P. Ferrera, M. Bianchi, and A. Casuccio Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose J Pain Symptom Manage 27 2004 352 359
10. Mercadante S, Ferrera P, Villari P, Arcuri E. Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management. Anesth Analg 2005;100:1540.
11. M. Sjoberg, L. Appelgren, and S. Einarsson Long-term intrathecal morphine and bupivacaine in refractory cancer pain. I. Results from the first series of 52 patients Acta Anaesthesiol Scand 35 1991 30 43
12. M. Sjoberg, P. Nitescu, L. Appelgren, and I. Curelaru Long-term intrathecal morphine and bupivacaine in patients with refractory cancer pain Anesthesiology 80 1994 284 297
13. R. Rauck, D. Cherry, and M. Boyer Long-term intrathecal opioid therapy with a patient-activated implanted delivery system for the treatment of refractory cancer pain J Pain 4 2003 441 447
14. E. Buchser, A. Durrer, D. Chédel, and J. Mustaki Efficacy of intrathecal bupivacaine: how important is the flow rate? Pain Med 5 2004 248 252
15. S. Mercadante, P. Villari, P. Ferrera, and E. Arcuri Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain Anesth Analg 97 2003 187 189
16. P. Nitescu, L. Appelgren, and L.E. Linder Epidural versus intrathecal morphine-bupivacaine: assessment of consecutive treatments in advanced cancer pain J Pain Symptom Manage 5 1990 18 26
17. B.J. Crul, and E.M. Delhaas Technical complications during long-term subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases Reg Anesth 16 1991 209 213
18. D. Carr, L. Goudas, and W. Denman Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study Pain 108 2004 17 27